Dr. Reddy's Laboratories Company Description

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide.

It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments.

The company’s Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business.

The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products.

This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements.

The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services.

The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology.

Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Dr. Reddy's Laboratories Limited

Country	India
Founded	1984
Industry	Pharmaceutical Preparations
Employees	27,048
CEO	Erez Israeli

Contact Details

Address: 8-2-337, Road No. 3 Hyderabad, 500034 India
Phone	91 40 4900 2900
Website	drreddys.com

Stock Details

Ticker Symbol	500124
Exchange	Bombay Stock Exchange
Fiscal Year	April - March
Reporting Currency	INR
SIC Code	2834

Key Executives

Name	Position
Erez Israeli	Chief Executive Officer
Mannam Venkatanarasimham	Chief Financial Officer
Richa Periwal	Head of Investor Relations